Classic Warrior ponders if CRBP was fast tracked by the FDA to Phase 3? If you believe in Bucillamine, stay vested. The warrior was expecting the drop, so it was not hard to accept. There was no pain or headaches from the drop in pps. Gaining all that cash for a $.04 drop is a yawn. $RVVTF will prevail. It does appear that the speed of the enrollment was quite slow. A trial in Asia would have been finished by now, results would have been interpreted and the warrior would be retired. Anyway, we wait with a little more cash in our pockets to finish the trials.
ps. The warrior is still hoping for EUA after the first 210.
pps. Pennys- Come on Man! Seriously?
ppps. The riddle remains: Why sell shares if greatness is around the corner? Results may be pushed back a few, but MF owes his shareholders an update by 2/1/21. Maybe the psychedelic growth, ventures, and partnerships are going to be more costly than previously thought? Who knows? So much goes on behind the scenes that we just simply don't have the information. Trust MF or not, this guy is all in. Peace. By Tuesday, we are back to $.46. Let's go!!!!
Market Data 
Markets 
